Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Supernus Pharma (SUPN) Misses Q4 EPS by 25c
February 28, 2023 4:15 PM ESTSupernus Pharma (NASDAQ: SUPN) reported Q4 EPS of $0.43, $0.25 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $167.33 million versus the consensus estimate of $180.38 million.
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
... More